- Telehealth Visits
- Insurance plan information
Harold Chapman, MD
Critical Care Medicine- Telehealth Visits
- Insurance plan information
Harold Chapman, MD
Critical Care Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
An expert in the treatment of lung disorders and research on such conditions, Dr. Harold Chapman serves as chief of UCSF's pulmonary division.
Chapman received his medical degree from the University of Alabama. He completed a residency in internal medicine at University of Utah Health. He completed fellowships in pulmonary medicine at University of Utah Health and the Veterans Affairs Salt Lake City Health Care System.
Chapman serves on numerous editorial and advisory boards at UCSF.
Education & training
Board certification
- Pulmonary Disease, American Board of Internal Med/Pulmonary Disease
- Internal Medicine, American Board of Internal Medicine
Degree
- MD, University of Alabama School of Medicine
My expertise
Specialties
Conditions
- Sarcoidosis
- Pulmonary Hypertension
- Lung Cancer
- Interstitial Lung Disease
- Idiopathic Pulmonary Fibrosis (IPF)
- Hypersensitivity Pneumonitis
- Chronic Obstructive Pulmonary Disease
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.